Matthew J. Desch filed an Initial Statement of Beneficial Ownership (Form 3) reporting his relationship to Verisign, Inc. (VRSN) as a Director. The event date is 10/06/2025 and the filing is dated 10/08/2025. The form discloses zero shares of common stock beneficially owned and no derivative securities.
Verisign, Inc. disclosed the appointment of Mr. Desch to its Board of Directors effective October 6, 2025. He currently serves as Chief Executive Officer and a director of Iridium Communications Inc., a mobile satellite communications company, a role he has held since 2009. As a non-employee director, Mr. Desch will receive an annual cash retainer of $50,000 and an annual equity award of $250,000 in restricted stock units, both prorated for partial-year service for new directors.
The company will enter into its standard indemnity agreement to advance expenses and indemnify him for liabilities arising from his board service. The filing states there were no related arrangements or transactions requiring disclosure under applicable rules.
Form 144 notice for Verisign, Inc. (VRSN): An insider submitted a Form 144 to report a proposed sale of 501 common shares through Morgan Stanley Smith Barney LLC on 10/07/2025, with an aggregate market value of $135,705.87. The securities were acquired as restricted stock from the issuer on 02/15/2025 and the filer indicates prior small sales of 501-share lots on 07/08/2025, 08/05/2025, 08/12/2025, 09/02/2025, and 09/09/2025, each for roughly $132k–$143k gross proceeds. The filer certifies they are unaware of undisclosed material adverse information and follows Rule 144 disclosure requirements.
D. James Bidzos, Verisign Inc. (VRSN) executive chairman, president and CEO, reported insider sales on 09/18/2025. He sold a total of 2,000 shares across four transactions at weighted-average prices in the ranges $285.94–$286.35, $287.05–$287.77 and $288.08–$288.95, and one trade at $289.32. Following these disposals his reported beneficial ownership stood at 476,438.7009 shares. The Form 4 indicates the transactions were covered by a written plan intended to satisfy Rule 10b5-1 affirmative defense.
Verisign insider transactions: D. James Bidzos, who is listed as Exec. Chairman, President and CEO, reported multiple sales of Verisign common stock on September 16-17, 2025. The filings show five sale entries totaling 7,000 shares sold in aggregate at weighted-average prices ranging from approximately $286.591 to $290.0325 per share, with individual trade-weighted price ranges disclosed in the explanations. After these reported disposals, the reporting person beneficially owned 478,438.7009 shares of Verisign common stock. The Form 4 was signed by a power of attorney on behalf of Mr. Bidzos.
VeriSign insider sales by CEO D. James Bidzos: Between September 9-11, 2025 the reporting person sold a total of 9,000 shares of VeriSign common stock in multiple transactions at prices ranging approximately from $280.51 to $289.55. The transactions were reported as made pursuant to a written Rule 10b5-1 plan (box checked). The filing notes inclusion of 134.7365 dividend-equivalent restricted stock units acquired August 27, 2025, in respect of previously granted restricted stock units. Following these reported sales, the reporting person’s beneficial ownership is shown as 485,438.7009 shares. The form is a standard Section 16 disclosure of insider sales with weighted-average prices and ranges disclosed for multi-price trades.
VeriSign executive Thomas C. Indelicarto, listed as EVP, General Counsel & Secretary, reported a sale of 501 shares of VeriSign common stock on 09/09/2025 at $282.28 per share. After the reported transaction he beneficially owns 35,191.2718 shares directly. The Form 4 was signed on 09/10/2025. The filing is a routine insider sale; no derivatives or additional transactions are reported.
Form 144 filed for VeriSign, Inc. (VRSN) reporting proposed and recent sales of common stock by an insider. The notice lists a proposed sale of 501 shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $141,422.28, scheduled approximately 09/09/2025 on NASDAQ. The filing identifies the shares as restricted stock acquired from the issuer on 08/15/2025 and 02/15/2025 in amounts of 260 and 241 shares respectively.
The filing also discloses six recorded sales by the same person of 501 shares each between 06/10/2025 and 09/02/2025, with gross proceeds shown for each sale. The filer affirms compliance with Rule 144 and certifies no undisclosed material adverse information.
Thomas C. Indelicarto, EVP, General Counsel & Secretary of VeriSign, Inc. (VRSN), reported an open-market sale of 501 shares of VeriSign common stock on 09/02/2025 at a reported price of $270.46 per share. After the sale, he beneficially owned 35,692.2718 shares. The filing indicates the sale was made pursuant to a written plan intended to satisfy the Rule 10b5-1 affirmative defense. The filing also notes the acquisition of 49.4107 dividend-equivalent restricted stock units on 08/27/2025 relating to previously granted restricted stock units under the company’s equity incentive plan.
VeriSign Inc. (VRSN) Form 144 notice reports a proposed sale of 501 common shares through Morgan Stanley Smith Barney LLC on 09/02/2025 with an aggregate market value of $135,500.46. The shares were acquired as restricted stock from the issuer on 08/15/2025. The filer also disclosed six prior small common-share sales during the past three months, each for 501 shares, producing total gross proceeds of $835,279.73. Outstanding shares are listed as 93,400,000, indicating the reported sales are a very small fraction of shares outstanding.